Molefy pharma develops breakthrough therapies for neurodegenerative diseases, halting progression and restoring health.
Molefy pharma has raised $999K in total funding. The most recent round was Grant. The last funding was announced in December 2025.
Molefy pharma's investors include The ALS Association.
Molefy pharma is headquartered in San Cristóbal De La Laguna, Spain.
Molefy pharma develops breakthrough therapies for neurodegenerative diseases, halting progression and restoring health.
Molefy pharma is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Molefy pharma — Funding & Investors." VCBacked, December 4, 2025, https://www.vcbacked.co/company/molefy-pharma. Accessed August 14, 2026.
VCBacked. (2025). Molefy pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/molefy-pharma
{{cite web |title=Molefy pharma — Funding & Investors |url=https://www.vcbacked.co/company/molefy-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated